Medicis Announces Approval of Additional Strengths of Solodyn(R) - MarketWatch (press release)
Posted by admin! / Under Acne Vulgaris
Medicis Announces Approval of Additional Strengths of Solodyn(R) MarketWatch (press release) When used as directed, SOLODYN is well tolerated and effective for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in ... Medicis Says FDA Approves Additional Strengths Of Solodyn For Acne-Treatment ... |
Published on Thursday 2nd of September 2010 02:59:13 PM
